New research from Griffith University has shown that damage to the lining inside the nose increases the risk of bacteria sneaking into the brain via nerves, potentially causing long-term health issues. PhD candidate Heidi Walkden and her colleagues from the Menzies Health Institute Queensland, Institute for Glycomics and Griffith Institute for Drug Discovery, in collaboration with Queensland […]

MBA Lawyers, a long established and well-respected law firm based on the Gold Coast, has signed a memorandum of understanding to become a major corporate sponsor of the Malaria Vaccine Project. Established in March 2017, the Malaria Vaccine Project is a partnership between Rotary District 9640 and Griffith University’s Institute for Glycomics which aims to […]

Researchers announce two new treatments with potential to prevent and cure gonorrhoea.

Griffith’s Institute for Glycomics and Germany’s Bremen University have received funding to continue a research exchange to develop a drug delivery system to treat Non-Hodgkin’s Lymphoma.

Research done by Griffith University and the Hefei Institute of Material Science of the Chinese Academy of Sciences proposes that deep mutational scanning in combination with high throughput sequencing alone can be used to infer highly accurate structures for proteins and RNAs (Ribonucleic acids) without having to use expensive equipment. Understanding the structural clues behind […]

Some of Griffith University’s most outstanding researchers have been honoured at the Institute for Glycomics Research Excellence Awards evening. Attended by more than one hundred guests, the aim of the cocktail-style presentation event was to acknowledge the Institute’s excellent research achievements and celebrate a remarkable milestone, the Institute for Glycomics 20th Anniversary. Awards from the […]

Director and Head of Research for the Institute for Glycomics Professor Mark von Itzstein AO has been honoured with the Gold Coast Citizen of the Year award.

Human clinical trial success of new drug candidate to treat viral arthritis caused by mosquito-borne infections.

A world-first trial for a promising gonorrhoea vaccine will be led by Griffith University’s Institute for Glycomics and the Kirby Institute at UNSW Sydney. The $2.7 million study incorporates five Australian universities and three health districts and providers, and will test whether a meningococcal B vaccine protects against gonorrhoea in gay and bisexual men. “Gonorrhoea […]

Griffith University has been awarded $3,376,073 for ARC Discovery and Linkage Projects.

Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.

Method to better predict RNA secondary structures could become tool to better understand implication in various diseases such as cancer. 

Shiitake, Reishi, and Maitake extracts enhance immune cell responses to boost overall immune system.

A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock caused by invasive streptococcal disease, which kills more than 160,000 people every year. “Streptococcal toxic shock syndrome is an acute condition like meningococcus – if you get exposed to the organism you can be dead […]

NHMRC funding for Griffith researchers totals $5,167,963.

‘Cell suicide’ study could unlock treatment for brain diseases and development of disease-resistant plants. 

National Science Week will see a range of events celebrate Griffith's scientific expertise.

A new scientific discovery, thanks to one of the research groups at Griffith University’s Institute for Glycomics, is providing new hope for the development of an effective treatment of Hand, Foot and Mouth Disease (HFMD). Led by the Institute’s Founder and Director, Professor Mark von Itzstein AO, the research group has just published a paper […]